Kintsugi

Kintsugi is a health technology startup based in Berkeley, California, founded in 2019 by Grace Chang and Rima Seiilova-Olson. The company specializes in AI-driven voice biomarker technology that detects signs of clinical depression and anxiety from short clips of free-form speech. Kintsugi aims to enhance access to mental healthcare by supporting clinicians in screening and triage processes, ultimately improving population insights.

The company's core product, Kintsugi Voice (KiVA), is an API platform that analyzes voice data in real-time to assess mental health risks while ensuring patient anonymity. Kintsugi serves a variety of clients, including payers, providers, health systems, and pharmaceutical companies, optimizing care delivery and helping to identify at-risk patients. With a dataset significantly larger than its competitors, Kintsugi provides valuable insights for both scientific research and healthcare applications. The company has received recognition from the National Science Foundation and has raised over $26.5 million to expand its operations and partnerships.